Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human SGCG Protein, N-His

Catalog #:   YHG48801 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q13326
Protein length: Met68-Leu291
Overview

Catalog No.

YHG48801

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met68-Leu291

Predicted molecular weight

26.64 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q13326

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Gamma-sarcoglycan, SGCG, 35 kDa dystrophin-associated glycoprotein, 35DAG, Gamma-SG

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human SGCG Protein
References

Inherited and de novo variants in young females potentially associated with pelvic organ prolapse., PMID:40157519

Sarcoglycanopathies: From clinical diagnosis to new promising therapies., PMID:40129306

Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis., PMID:39909125

The Proteomic Landscape of the Coronary Accessible Heart Cell Surfaceome., PMID:39790063

Profiling of pathogenic variants in Japanese patients with sarcoglycanopathy., PMID:39755676

Phenotypic Variability of LGMD 2C/R5 in a Genetically Homogenous Group of Bulgarian Muslim Roma., PMID:39336735

Genetic spectrum of sarcoglycanopathies in a cohort of Russian patients., PMID:38876406

Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study., PMID:38491364

Single-centre experience with autosomal recessive limb-girdle muscular dystrophy: case series and literature review., PMID:37852290

Combined sequence and copy number analysis improves diagnosis of limb girdle and other myopathies., PMID:37688281

Targeted next-generation sequencing determined a novel SGCG variant that is associated with limb-girdle muscular dystrophy type 2C: A case report., PMID:36992678

Systemic γ-sarcoglycan AAV gene transfer results in dose-dependent correction of muscle deficits in the LGMD 2C/R5 mouse model., PMID:36816759

Homozygous Inversion on Chromosome 13 Involving SGCG Detected by Short Read Whole Genome Sequencing in a Patient Suffering from Limb-Girdle Muscular Dystrophy., PMID:36292638

Comparative genomic analyses of multiple backcross mouse populations suggest SGCG as a novel potential obesity-modifier gene., PMID:35796564

Clinical, genetic profile and disease progression of sarcoglycanopathies in a large cohort from India: high prevalence of SGCB c.544A > C., PMID:35416532

Novel γ-sarcoglycan interactors in murine muscle membranes., PMID:35065666

The utility of whole-exome sequencing in accurate diagnosis of neuromuscular disorders in consanguineous families in Jordan., PMID:34624274

Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy., PMID:34515763

Sarcoglycanopathies: an update., PMID:34404573

Elucidation of the Genetic Cause in Dutch Limb Girdle Muscular Dystrophy Families: A 27-Year's Journey., PMID:33386810

The etiology of rhabdomyolysis: an interaction between genetic susceptibility and external triggers., PMID:32978841

New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy., PMID:32875335

SGCG rs679482 Associates With Weight Loss Success in Response to an Intensively Supervised Outpatient Program., PMID:32527767

Expression, purification, and structural analysis of the full-length human integral membrane protein γ-sarcoglycan., PMID:31682967

Association of a novel seven-gene expression signature with the disease prognosis in colon cancer patients., PMID:31612869

A gene-edited mouse model of limb-girdle muscular dystrophy 2C for testing exon skipping., PMID:31582396

Childhood onset limb-girdle muscular dystrophies in the Aegean part of Turkey., PMID:30838351

Molecular genetic study of Calpainopathy in Iran., PMID:30056071

A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease., PMID:29986096

Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers., PMID:29720576

Contrast-Enhanced Near-Infrared Optical Imaging Detects Exacerbation and Amelioration of Murine Muscular Dystrophy., PMID:29271299

Severe murine limb-girdle muscular dystrophy type 2C pathology is diminished by FTY720 treatment., PMID:27935071

γ-sarcoglycan and dystrophin mutation spectrum in an Algerian cohort., PMID:27759885

Crystal Structures of SgcE6 and SgcC, the Two-Component Monooxygenase That Catalyzes Hydroxylation of a Carrier Protein-Tethered Substrate during the Biosynthesis of the Enediyne Antitumor Antibiotic C-1027 in Streptomyces globisporus., PMID:27560143

A rare form of limb girdle muscular dystrophy (type 2E) seen in an Iranian family detected by autozygosity mapping., PMID:27276190

Analysis of lncRNAs expression in UVB-induced stress responses of melanocytes., PMID:26596215

Biochemical and Functional Comparisons of mdx and Sgcg(-/-) Muscular Dystrophy Mouse Models., PMID:26064876

The Sarcoglycan complex is expressed in the cerebrovascular system and is specifically regulated by astroglial Cx30 channels., PMID:25698924

Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy., PMID:25070948

Sarcolemmal alpha and gamma sarcoglycan protein deficiencies in Turkish siblings with a novel missense mutation in the alpha sarcoglycan gene., PMID:24742800

Carrier frequency of the c.525delT mutation in the SGCG gene and estimated prevalence of limb girdle muscular dystrophy type 2C among the Moroccan population., PMID:24552312

Puerto Rican founder mutation G787A in the SGCG gene: a case report of 2 siblings with LGMD 2C., PMID:24534832

Identification of HMX1 target genes: a predictive promoter model approach., PMID:23946633

Hints of unique genetic effects for type 2 diabetes in India., PMID:23613552

Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India., PMID:23300278

The superhealing MRL background improves muscular dystrophy., PMID:23216833

Acute ischemic stroke in gamma-sarcoglycanopathy., PMID:23040950

Impact of single-nucleotide polymorphisms at the TP53-binding and responsive promoter region of BCL2 gene in modulating the phenotypic variability of LGMD2C patients., PMID:22367371

Motor chip: a comparative genomic hybridization microarray for copy-number mutations in 245 neuromuscular disorders., PMID:21896784

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human SGCG Protein, N-His [YHG48801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only